1
0
0
(1 - 17 von 17
)
Transfection of Dendritic Cells with in Vitro-Transcribed CMV ...
www.cell.com
von A Heine · · Zitiert von: 26 — Tobias Holderried. Tobias Holderried. Affiliations. Department of Hematology, Oncology, and Immunology, University of Tübingen... › fulltext
and CD4 -Mediated CMV-Specific T Cell - ProQuest
www.proquest.com
von A Heine · · Zitiert von: 26 — Annkristin Heine,1,* Frank Grünebach,1,* Tobias Holderried,1 Silke Appel,1 Markus M. Weck,1. Daniela Dörfel,1 Christian Sinzger,2 and Peter Brossart1,y. › openview › 1.pdf
and CD4 -Mediated CMV-Specific T Cell - ebsco
web.s.ebscohost.com
von A Heine · · Zitiert von: 26 — Annkristin Heine,1,* Frank Grünebach,1,* Tobias Holderried,1 Silke Appel,1 Markus M. Weck,1. Daniela Dörfel,1 Christian Sinzger,2 and Peter Brossart1,y. › login
Transfection of Dendritic Cells with in Vitro-Transcribed ...ScienceDirect.com
www.sciencedirect.com
von A Heine · · Zitiert von: 26 — Annkristin Heine 1 † , Frank Grünebach 1 † , Tobias Holderried 1 , Silke Appel 1 , Markus M. Weck 1 , Daniela Dörfel 1 , Christian Sinzger 2 , Peter Brossart ... von A Heine · · Zitiert von: 26 — Annkristin Heine 1 † , Frank Grünebach 1 † , Tobias Holderried 1 , Silke Appel 1 , Markus M. Weck 1 , Daniela Dörfel 1 , Christian Sinzger 2 , Peter Brossart ...
Regulatory CD8 T cells that recognize Qa-1 expressed by ...jstor
www.jstor.org
von JY Choi · · Zitiert von: 27 — ... Tobias Holderried and Xiaolei Tang). Induction of longstanding immunologic tolerance is essential for survival of transplanted organs and ... von JY Choi · · Zitiert von: 27 — ... Tobias Holderried and Xiaolei Tang). Induction of longstanding immunologic tolerance is essential for survival of transplanted organs and ...
Higher number of multidisciplinary tumor board meetings per ...BMC Cancer
bmccancer.biomedcentral.com
von M Freytag · · Zitiert von: 56 — Bauernfeind, Tobias Holderried, Martin Schumacher, Georg Feldmann & Mario Heine. Department of Internal Medicine I, University Hospital Bonn ... von M Freytag · · Zitiert von: 56 — Bauernfeind, Tobias Holderried, Martin Schumacher, Georg Feldmann & Mario Heine. Department of Internal Medicine I, University Hospital Bonn ...
Total marrow irradiation versus total body irradiation using ...Springer
link.springer.com
von M Köksal · · Zitiert von: 7 — Annkristin Heine, Tobias Holderried & Peter Brossart. Deprtment of Radiation Oncology, Sana Hospital Offenbach, Offenbach, Germany. Eleni Zoga. von M Köksal · · Zitiert von: 7 — Annkristin Heine, Tobias Holderried & Peter Brossart. Deprtment of Radiation Oncology, Sana Hospital Offenbach, Offenbach, Germany. Eleni Zoga.
analysis of organs at risk by dose and its effect on blood ...Springer
link.springer.com
von M Köksal · · Zitiert von: 6 — Tobias Holderried,; Peter Brossart,; Thomas Müdder & … Leonard C ... Annkristin Heine, Tobias Holderried & Peter Brossart. Authors. Mümtaz ... von M Köksal · · Zitiert von: 6 — Tobias Holderried,; Peter Brossart,; Thomas Müdder & … Leonard C ... Annkristin Heine, Tobias Holderried & Peter Brossart. Authors. Mümtaz ...
Antibody-mediated blockade of the IL23 receptor ...PNAS
www.pnas.org
von AE Wight · · Zitiert von: 12 — ... Tobias Holderried and Khashayarsha Khazaie. April 28, (18) e https://doi.org pnas , Metrics. Total Views2,766. von AE Wight · · Zitiert von: 12 — ... Tobias Holderried and Khashayarsha Khazaie. April 28, (18) e https://doi.org pnas , Metrics. Total Views2,766.
Conversion from MRD Positive to Negative Status in AML ...The Conference Exchange
ash.confex.com
von A van de Loosdrecht · · Zitiert von: 2 — ... Tobias Holderried, MD5*, Uwe Platzbecker, MD6, Jacqueline J Cloos7* and Jeroen Rovers, MD, PhD8*. 1Department of Hematology, Amsterdam ... von A van de Loosdrecht · · Zitiert von: 2 — ... Tobias Holderried, MD5*, Uwe Platzbecker, MD6, Jacqueline J Cloos7* and Jeroen Rovers, MD, PhD8*. 1Department of Hematology, Amsterdam ...
Evaluation of factors associated with survival in allogeneic ...National Institutes of Health (NIH) (.gov)
pubmed.ncbi.nlm.nih.gov
von M Serries · · Zitiert von: 1 — Tobias Holderried , Peter Brossart , Katjana Schwab. Affiliation. 1 Department of Internal Medicine 3, Hematology and Medical Oncology ... von M Serries · · Zitiert von: 1 — Tobias Holderried , Peter Brossart , Katjana Schwab. Affiliation. 1 Department of Internal Medicine 3, Hematology and Medical Oncology ...
P1387: TREATMENT WITH A LEUKEMIA-DERIVED ...National Institutes of Health (NIH) (.gov)
www.ncbi.nlm.nih.gov
von H van Zeeburg · · Zitiert von: 1 — Tobias Holderried. 4Universiätsklinikum Bonn (UKB), Bonn, Germany. Find articles by Tobias Holderried. Catharina VAN Elssen. 5Maastricht University Medical ... von H van Zeeburg · · Zitiert von: 1 — Tobias Holderried. 4Universiätsklinikum Bonn (UKB), Bonn, Germany. Find articles by Tobias Holderried. Catharina VAN Elssen. 5Maastricht University Medical ...
Prevalence, therapy and tumour response in patients with ...Europe PMC
europepmc.org
von SH Verspohl · · Zitiert von: 12 — ... Tobias Holderried, Charlotte Behning, Peter Brossart, and Valentin S. Schäfer. Sophia H. Verspohl. Clinic for Internal Medicine III, Department of Oncology ... von SH Verspohl · · Zitiert von: 12 — ... Tobias Holderried, Charlotte Behning, Peter Brossart, and Valentin S. Schäfer. Sophia H. Verspohl. Clinic for Internal Medicine III, Department of Oncology ...
Prevalence, therapy and tumour response in patients with ...Sage Journals
journals.sagepub.com
von SH Verspohl · · Zitiert von: 13 — Verspohl, Tobias Holderried, […], Charlotte Behning, Peter Brossart, and ... Tobias Holderried. Clinic for Internal Medicine III, Department of Oncology ... von SH Verspohl · · Zitiert von: 13 — Verspohl, Tobias Holderried, […], Charlotte Behning, Peter Brossart, and ... Tobias Holderried. Clinic for Internal Medicine III, Department of Oncology ...
Prevalence, therapy and tumour response in SAGE Journals
journals.sagepub.com
von SH Verspohl · · Zitiert von: 7 — Sophia H. Verspohl, Tobias Holderried, […], Charlotte Behning, Peter Brossart, and Valentin S. Schäfer https://orcid.org › abs
Prevalence, therapy and tumour response in patients NCBI
www.ncbi.nlm.nih.gov
von SH Verspohl · · Zitiert von: 7 — Tobias Holderried, Clinic for Internal Medicine III, Department of Oncology, Haematology, Rheumatology and Clinical Immunology, University Hospital of Bonn, ... › pmc
Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus ...
pubmed.ncbi.nlm.nih.gov
von R Zeiser · · Zitiert von: 83 — ... Herrad Baurmann, Guido Kobbe, Tobias Holderried, Jan Moritz Middeke, Julia Winkler, Klaus Daniel Stachel, Gesine Bug, Robert Zeiser, ... › ...
Alle Infos zum Namen "Tobias Holderried"
Verwandte Suchanfragen zu Tobias Holderried
Rolf Tämmerich Peter Brossart Martin Schumacher | Michael Heuser Georg Feldmann Ahmed Gawish | Petra Hipp Laura Edler Milo Last |
Person "Holderried" (2) Vorname "Tobias" (39044) Name "Holderried" (87) |
sortiert nach Relevanz / Datum